Breaking News Instant updates and real-time market news.

GS

Goldman Sachs

$199.58

-2.97 (-1.47%)

, BAC

Bank of America

$29.14

-0.16 (-0.55%)

10:44
01/22/19
01/22
10:44
01/22/19
10:44

BofA CEO sees another round of bank consolidation, Bloomberg reports

Bank of America (BAC) CEO Brian Moynihan says he sees another round of U.S. bank mergers and that the creation of a "megabank" could happen again as there are thousands of banks operating across the country, Bloomberg reports, citing comments made on a panel at the World Economic Forum in Davos, Switzerland. "How does somebody emerge? The same way we emerged," Moynihan said, adding that "The emergence will come out of the consolidation of another round of people which still has to happen in the United States. There are now 6,000 odd banks, and you'll find them continuing to consolidate." Other traded companies in the space include Citi (C), Goldman Sachs (GS), JPMorgan (JPM), Morgan Stanley (MS), U.S. Bancorp (USB) and Wells Fargo (WFC). Reference Link

GS

Goldman Sachs

$199.58

-2.97 (-1.47%)

BAC

Bank of America

$29.14

-0.16 (-0.55%)

JPM

JPMorgan

$102.89

-1.7 (-1.63%)

C

Citi

$61.76

-1.38 (-2.19%)

WFC

Wells Fargo

$49.80

-0.21 (-0.42%)

USB

U.S. Bancorp

$50.12

-0.11 (-0.22%)

MS

Morgan Stanley

$42.63

-1.09 (-2.49%)

  • 24

    Jan

  • 11

    Feb

  • 12

    Feb

  • 26

    Feb

  • 03

    Mar

  • 12

    Apr

  • 28

    May

  • 13

    Jul

  • 13

    Jul

  • 12

    Oct

GS Goldman Sachs
$199.58

-2.97 (-1.47%)

01/17/19
JMPS
01/17/19
NO CHANGE
JMPS
Market Perform
JMP says Goldman Sachs took 'big step' in repairing sentiment with Q4 report
Goldman Sachs' core earnings results were better than Street expectations, but the bigger story is around the enhanced detail provided by the firm with earnings, according to JMP Securities analyst Devin Ryan. He thinks the firm took "a big step toward repairing investor sentiment" and believes the move in shares with earnings was warranted, Ryan tells investors. While he also would not be surprised to see some additional relief in the near term, Ryan thinks the 1MDB overhang will likely persist. He maintains a Market Perform rating on Goldman shares, citing the 1MDB uncertainty, but thinks the stock is "becoming increasingly attractive."
01/17/19
BMOC
01/17/19
NO CHANGE
Target $262
BMOC
Market Perform
Goldman Sachs price target lowered to $262 from $276 at BMO Capital
BMO Capital analyst James Fotheringham lowered his price target on Goldman Sachs to $262 and kept his Market Perform rating after its Q4 results, saying that while it beat on revenues, its non-comp expenses are seen rising. The analyst adds that he is "gratified" by the "value-restoring" rebound in bank stocks after the December rout and anticipates "relatively benign system-wide fundamental credit quality over the next two years." Fotheringham also lowers his FY19 EPS view by 1% to $24.85 to reflect his outlook for higher expenses, stating that other large -cap banks, specialty lenders, and financial technology stocks offer investors a "greater opportunity".
01/17/19
WELS
01/17/19
NO CHANGE
Target $250
WELS
Outperform
Goldman Sachs price target raised to $250 from $235 at Wells Fargo
Wells Fargo analyst Mike Mayo raised his price target for Goldman Sachs to $250 from $235 following better than expected Q4 results, higher year-over-year backlogs, and better capital market conditions per the CFO. The analyst reiterates an Outperform rating on the shares.
01/17/19
OPCO
01/17/19
NO CHANGE
Target $272
OPCO
Outperform
Goldman Sachs price target raised to $272 from $257 at Oppenheimer
Oppenheimer analyst Chris Kotowski raised his price target for Goldman Sachs to $272 from $257 after an "excellent quarter for an oversold and undervalued stock." The analyst reiterates an Outperform rating on the shares.
BAC Bank of America
$29.14

-0.16 (-0.55%)

01/09/19
UBSW
01/09/19
UPGRADE
Target $32
UBSW
Buy
Bank of America upgraded to Buy from Neutral at UBS
UBS analyst Saul Martinez upgraded Bank of America (BAC) to Buy while lowering his price target for the shares to $32 from $33. The current share price offers an attractive entry point for a "leading franchise with proven risk and expense discipline and above peer profitability," Martinez tells investors in a research note. He believes that even with slowing revenue growth, Bank of America should continue improving efficiency metrics. Further, the company looks "comparatively well positioned to withstand a turn in credit," adds the analyst. Citigroup (C) remains Martinez's top pick among money centers.
01/09/19
01/09/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Nike (NKE) upgraded to Buy from Hold at HSBC. 2. Bank of America (BAC) upgraded to Buy from Hold at Edward Jones and to Buy from Neutral at UBS. 3. Wendy's (WEN) upgraded to Outperform from Perform at Oppenheimer with analyst Brian Bittner saying his work reveals an "intriguing setup" as Street's earnings and free cash flow estimates through 2020 have reset to levels that create an improved scenario for meets or beats, same-store sales appear to have drivers to accelerate into 2019 against conservative sell-side forecasts of sub-2% perpetually, new international strategy could unlock faster-than-expected long-term unit growth, and valuation at about 8% free cash flow yield implies very attractive upside/downside case against a highly stable financial model. 4. Akamai (AKAM) upgraded to Overweight from Sector Weight at KeyBanc with analyst Brandon Nispel saying his data tracker suggests upside to Q4 revenue, decreasing the risk to a Q1 and 2019 guide below expectations. 5. Foot Locker (FL) upgraded to Outperform from Neutral at Baird with analyst Jonathan Komp citing its relative valuation and strong backward looking indicators providing reason for optimism. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
01/08/19
UBSW
01/08/19
UPGRADE
UBSW
Buy
Bank of America upgraded to Buy from Neutral at UBS
01/09/19
EDJN
01/09/19
UPGRADE
EDJN
Buy
Bank of America upgraded to Buy from Hold at Edward Jones
JPM JPMorgan
$102.89

-1.7 (-1.63%)

01/08/19
MSCO
01/08/19
NO CHANGE
MSCO
Morgan Stanley cuts large cap bank estimates, but says stocks 'still cheap'
Morgan Stanley analyst Betsy Graseck lowered her large cap bank EPS estimates by an average of 3% and cut her target P/E multiples in the group an average of 2% due to her expectations for lower market-based revenues, slower NIM growth, risks to luxury consumer spending in 2019 and the drop in 2018 M&A volumes. Given this, she lowered her price targets by a median 6%, lowering her target for Bank of America (BAC) to $40 from $42, for Citi (C) to $88 from $94 and for JPMorgan (JPM) to $149 from $153. However, as a group she thinks large cap bank stocks still look cheap, as they are largely pricing a recession, which is not her base case. In terms of her top picks, Graseck identifies Bank of America, JPMorgan and State Street (STT).
01/08/19
JEFF
01/08/19
DOWNGRADE
Target $110
JEFF
Hold
JPMorgan downgraded to Hold from Buy at Jefferies
Jefferies analyst Ken Usdin downgraded JPMorgan (JPM) to Hold from Buy and lowered his price target on the stock to $110 from $130, as he believes continued outperformance of the best performer among large cap banks in 2018 "may be more governed" in 2019 as he expects negative EPS revisions and believes that revenues could fall short of consensus expectations for both NII and fees. Among large cap banks, Usdin also downgraded SunTrust (STI) and U.S. Bancorp (USB), both to Hold, this morning.
01/16/19
BMOC
01/16/19
NO CHANGE
Target $123
BMOC
Market Perform
JPMorgan price target lowered to $123 at BMO Capital on credit-driven Q4 miss
BMO Capital analyst James Fotheringham nudges his price target on JPMorgan down to $123 from $124 and kept his Market Perform rating on the shares after the bank posted a fees/credit-driven earnings miss in Q4. The analyst notes that the price decline in bank stocks was "value restoring" for the sector and still sees a " relatively benign system-wide fundamental credit quality over the next two years". Fotheringham adds that better values in financials exist elsewhere, with JPMorgan trading at two-year forward multiples that are "only slightly below its long-term historical average".
01/08/19
01/08/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Unilever (UN, UL) downgraded to Neutral from Buy at UBS. 2. General Dynamics (GD) downgraded to Hold from Buy at Jefferies with analyst Sheila Kahyaoglu saying despite a portfolio of "marquee assets," the company's earnings "lack momentum." 3. Principal Financial (PFG) downgraded to Neutral from Buy at Goldman Sachs with analyst Alex Scott saying he sees less upside in the shares relative to other names in his life insurance coverage universe. 4. JPMorgan (JPM), SunTrust (STI), and U.S. Bancorp (USB) were downgraded to Hold from Buy at Jefferies. 5. Maxar Technologies (MAXR) downgraded to Underperform from Neutral at Credit Suisse, to Sell at Veritas, to Market Perform from Outperform at BMO Capital, and to Sector Perform at National Bank. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
C Citi
$61.76

-1.38 (-2.19%)

01/15/19
JEFF
01/15/19
NO CHANGE
Target $64
JEFF
Hold
Citi price target raised to $64 from $61 at Jefferies
Jefferies analyst Ken Usdin raised his price target for Citi to $64 saying the bank in Q4 "powered through" a revenue and earnings miss with better than expected credit metrics. The analyst raised is 2019 earnings per share estimate by 25c to $7.75 and 2020 estimate by 35c to $9.15. However, he keeps a Hold rating on Citi shares.
01/16/19
STPT
01/16/19
DOWNGRADE
STPT
Hold
Citi downgraded to Hold from Buy at Standpoint Research
01/16/19
01/16/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Citi (C) downgraded to Hold from Buy at Standpoint Research. 2. Snap (SNAP) downgraded to Sector Perform from Outperform at RBC Capital with analyst Mark Mahaney citing the company's recent "mixed" pre-announcement and, more importantly, its latest disclosure of a "surprise" exit by its CFO Tim Stone who was on the job for less than a year. 3. Nordstrom (JWN) downgraded to Neutral from Conviction Buy at Goldman Sachs, to Neutral from Overweight at Atlantic Equities, and to Market Perform from Outperform at Telsey Advisory. 4. AB InBev (BUD) downgraded to Underperform from Hold at Jefferies with analyst Edward Mundy saying market share pressures, some of which have only recently become visible, will likely persist, and could lead to disappointment against high expectations of an emerging-led recovery. 5. HP Enterprise (HPE) downgraded to Equal Weight from Overweight at Morgan Stanley, while NetApp (NTAP) was downgraded to Underweight from Equal Weight. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
01/15/19
01/15/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Viacom (VIA, VIAB) upgraded to Buy from Hold at Pivotal Research with analyst Brian Wieser citing valuation. 2. Citi (C) upgraded to Outperform from Market Perform at BMO Capital with analyst James Fotheringham saying the bank's Q4 earnings and outlook were "just fine," but the stock trades "as if tragedy were nigh" at a 2-year forward multiple of 6.3-times earnings relative to the average historical valuation of 9.5-times. 3. Grainger (GWW) upgraded to Outperform from Neutral at Macquarie. 4. Helmerich & Payne (HP) upgraded to Overweight from Neutral at JPMorgan with analyst Sean Meakim saying while Helmerich is not immune from lower exploration and production spending, there is too much pessimism on the company's ability to sustain EBITDA in such an environment. 5. Akamai (AKAM) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst Keith Weiss citing his increased confidence in durable high single digit revenue growth and margins improving. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
WFC Wells Fargo
$49.80

-0.21 (-0.42%)

01/08/19
WOLF
01/08/19
DOWNGRADE
WOLF
Peer Perform
Wells Fargo downgraded to Peer Perform from Outperform at Wolfe Research
01/07/19
GSCO
01/07/19
DOWNGRADE
Target $144
GSCO
Neutral
PNC Financial downgraded to Neutral from Buy at Goldman Sachs
Goldman Sachs analyst Richard Ramsden downgraded PNC Financial (PNC) to Neutral and lowered his price target for the shares to $144 from $154. Commercial loan growth has fallen 7 percentage points and is likely to track industry growth rates more closely from here, Ramsden tells investors in a research note. Further, he thinks higher deposit betas could "hinder" PNC's net interest income growth and that the current valuation "appears fair on a relative basis." In an environment where the revenue outlook is uncertain, Bank of America (BAC) and Wells Fargo look best positioned, says Ramsden.
01/02/19
RBCM
01/02/19
UPGRADE
Target $48
RBCM
Sector Perform
Wells Fargo upgraded to Sector Perform from Underperform at RBC Capital
As noted earlier, RBC Capital analyst Gerard Cassidy upgraded Wells Fargo to Sector Perform but lowered his price target to $48 from $50. The analyst notes that his prior downgrade was related to expectations that the Federal Reserve's Cease & Desist Order would "seriously hamper" the bank's ability to operate in an "otherwise healthy banking environment." At current prices however, Cassidy contends that the stock "fully discounts" the bank's regulatory risks, also raising his Q4 earnings estimate by 8c to $1.28.
01/02/19
RBCM
01/02/19
UPGRADE
RBCM
Sector Perform
Wells Fargo upgraded to Sector Perform from Underperform at RBC Capital
USB U.S. Bancorp
$50.12

-0.11 (-0.22%)

11/27/18
11/27/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Hormel Foods (HRL) downgraded to Hold from Buy at Jefferies with analyst Akshay Jagdale citing valuation. 2. Wyndham Hotels & Resorts (WH) downgraded to Buy from Conviction Buy at Goldman Sachs while Wyndham Destinations (WYND) was downgraded to Neutral from Buy. 3. U.S. Bancorp (USB) downgraded to Hold from Buy at Deutsche Bank with analyst Matthew O'Connor citing valuation. 4. Macerich (MAC) downgraded to Underweight from Equal Weight at Morgan Stanley with analyst Richard Hill saying he believes the market is underappreciating the company's free cash flow declines in 2019 and 2020. 5. Athenahealth (ATHN) downgraded to Market Perform from Outperform at Wells Fargo with analyst Jamie Stockton saying he suspects a proxy will come out in the next week or two detailing the full process since June to try to sell the company, which ultimately resulted in Veritas Capital and Elliott Management making a $135 all-cash offer on November 12. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
01/04/19
OPCO
01/04/19
NO CHANGE
OPCO
Outperform
Oppenheimer sees 'poor' quarter for banks' capital markets businesses
Oppenheimer analyst Chris Kotowski previewed the Q4 outlook for financial institutions, telling investors in a research note that the significant market volatility in December suggests a poor quarter for the banks' capital markets businesses which are likely to persist into 1H19, adding that the weaker equity markets will likely limit ECM revenues. Kotowski says he believes the less banks pay for their shares in the current market turmoil, the more the stocks are worth in the long run. He continue to recommend Bank of America (BAC), Citi (C), CIT Group (CIT), Goldman Sachs (GS), Morgan Stanley (MS) and US Bancorp (USB).
01/08/19
JEFF
01/08/19
DOWNGRADE
Target $51
JEFF
Hold
U.S. Bancorp downgraded to Hold from Buy at Jefferies
Jefferies analyst Ken Usdin downgraded U.S. Bancorp (USB) to Hold from Buy and lowered his price target on the stock to $51 from $60 as he believes the company's higher premium, currently at its widest over the last five years, reflects the perception that the bank's profitability will hold up better than peers in any downturn. While he sees somewhat limited downside EPS revision risk for U.S. Bancorp, Usdin believes the stock is already reflecting this, he tells investors. Among large cap banks, Usdin also downgraded JPMorgan (JPM) and SunTrust (STI), both to Hold, this morning.
MS Morgan Stanley
$42.63

-1.09 (-2.49%)

01/17/19
GSCO
01/17/19
NO CHANGE
Target $47
GSCO
Neutral
Morgan Stanley maintaining financial targets may disappoint, says Goldman Sachs
Goldman Sachs analyst Richard Ramsden noted that Morgan Stanley's Q4 earnings came in "well below" his estimates and the consensus view due to revenue in the firm's two largest operating segments, institutional securities and wealth management, coming in 11% and 7%, respectively, below consensus expectations. He also thinks the fact that Morgan Stanely did not update any of its financial targets, leaving the ROTCE range of 11.5%-14.5% and wealth management margin range of 26%-28%, may be disappointing to some. Ramsden keeps a Neutral rating on Morgan Stanley shares with a $47 price target.
01/17/19
DBAB
01/17/19
NO CHANGE
Target $60
DBAB
Buy
Morgan Stanley post-earnings pullback a buying opportunity, says Deutsche Bank
Deutsche Bank analysts said that while Morgan Stanley's Q4 results were weaker than hoped and compared to peers, they don't view this as indicative of future results. Management seems optimistic revenues will recover and there "could be a nice snapback" in Q1 given that markets are recovering year-to-date, Deutsche Bank added. The firm maintains a Buy rating on Morgan Stanley shares with an unchanged price target of $60.
01/09/19
SBSH
01/09/19
UPGRADE
Target $48
SBSH
Buy
Morgan Stanley upgraded to Buy from Neutral at Citi
Citi analyst Keith Horowitz upgraded Morgan Stanley to Buy with a $48 price target. Higher market volatility can drive better markets revenue for Morgan Stanley over the course of 2019, Horowitz tells investors in a research note. Further, he thinks the company has the potential over the long term to raise its return on tangible equity targets on improved efficiency and lowering capital levels.
01/18/19
BMOC
01/18/19
NO CHANGE
Target $65
BMOC
Outperform
Morgan Stanley price target lowered to $65 from $72 at BMO Capital
BMO Capital analyst James Fotheringham lowered his price target on Morgan Stanley to $65 after its "revenue-driven" miss in Q4. The analyst keeps his Outperform rating on the shares however, stating that its 7.2-times two-year forward earnings multiple - a discount to the 10.4-times intrinsic value - implies a "deep value" for the stock price. Fotheringham further cites the release of 2019 CCAR rules, SEC returning of to work, and continued market recovery with higher equity values and lower interest rate volatility as Morgan Stanley's "near term catalysts".

TODAY'S FREE FLY STORIES

XYF

X Financial

$6.23

0.715 (12.98%)

17:23
03/18/19
03/18
17:23
03/18/19
17:23
Earnings
X Financial reports Q4 EPS 24c, two estimates 24c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

  • 20

    Mar

CADE

Cadence Bancorp

$20.24

0.51 (2.58%)

17:22
03/18/19
03/18
17:22
03/18/19
17:22
Hot Stocks
Cadence Bancorp President Samuel Tortorici buys almost $1M in company shares »

Cadence Bancorp President…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

CELP

Cypress Energy

$7.41

0.06 (0.82%)

17:22
03/18/19
03/18
17:22
03/18/19
17:22
Syndicate
Breaking Syndicate news story on Cypress Energy »

Cypress Energy files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Mar

JWN

Nordstrom

$44.21

0.465 (1.06%)

17:21
03/18/19
03/18
17:21
03/18/19
17:21
Syndicate
Breaking Syndicate news story on Nordstrom »

Nordstrom files automatic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GD

General Dynamics

$171.73

2.13 (1.26%)

17:20
03/18/19
03/18
17:20
03/18/19
17:20
Hot Stocks
General Dynamics awarded $2.04B Navy submarine material contract modification »

General Dynamics has been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

FFIN

First Financial

$61.60

0.44 (0.72%)

, MBFI

MB Financial

$47.20

0.63 (1.35%)

17:19
03/18/19
03/18
17:19
03/18/19
17:19
Hot Stocks
S&P announces changes to S&P MidCap 400, S&P SmallCap 600 indices »

First Financial…

FFIN

First Financial

$61.60

0.44 (0.72%)

MBFI

MB Financial

$47.20

0.63 (1.35%)

FOE

Ferro

$18.88

0.125 (0.67%)

FITB

Fifth Third

$28.74

0.42 (1.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Mar

  • 16

    Apr

  • 23

    Apr

  • 23

    Apr

FOE

Ferro

$18.88

0.125 (0.67%)

, FFIN

First Financial

$61.60

0.44 (0.72%)

17:17
03/18/19
03/18
17:17
03/18/19
17:17
Hot Stocks
Breaking Hot Stocks news story on Ferro, First Financial »

Ferro to replace First…

FOE

Ferro

$18.88

0.125 (0.67%)

FFIN

First Financial

$61.60

0.44 (0.72%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

FFIN

First Financial

$61.60

0.44 (0.72%)

, MBFI

MB Financial

$47.20

0.63 (1.35%)

17:17
03/18/19
03/18
17:17
03/18/19
17:17
Hot Stocks
First Financial to replace MB Financial in S&P 400 at open on 3/22 »

Fifth Third Bancorp…

FFIN

First Financial

$61.60

0.44 (0.72%)

MBFI

MB Financial

$47.20

0.63 (1.35%)

FITB

Fifth Third

$28.74

0.42 (1.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Mar

  • 16

    Apr

  • 23

    Apr

  • 23

    Apr

CUTR

Cutera

$18.00

-0.29 (-1.59%)

17:13
03/18/19
03/18
17:13
03/18/19
17:13
Hot Stocks
Cutera director Daniel Plants buys almost $1.5M in company shares »

Cutera director Daniel…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Mar

SMTX

SMTC Corp.

$4.41

-0.1 (-2.22%)

17:13
03/18/19
03/18
17:13
03/18/19
17:13
Syndicate
Breaking Syndicate news story on SMTC Corp. »

SMTC Corp. files $50M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Mar

  • 28

    May

SNE

Sony

$46.10

-0.16 (-0.35%)

, AAPL

Apple

$188.03

1.83 (0.98%)

17:09
03/18/19
03/18
17:09
03/18/19
17:09
Periodicals
PlayStation Vue now lets Apple TV users watch four channels at once, Verge says »

According to the…

SNE

Sony

$46.10

-0.16 (-0.35%)

AAPL

Apple

$188.03

1.83 (0.98%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VRRM

Verra Mobility

$10.89

0.15 (1.40%)

17:08
03/18/19
03/18
17:08
03/18/19
17:08
Earnings
Verra Mobility reports Q4 net ($38.0M) vs. ($29.2M) last year »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Mar

EQH

AXA Equitable

$20.86

0.09 (0.43%)

17:06
03/18/19
03/18
17:06
03/18/19
17:06
Syndicate
AXA Equitable files to sell 40M shares of common stock for holders »

In connection with the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DIS

Disney

$113.07

-1.89 (-1.64%)

17:04
03/18/19
03/18
17:04
03/18/19
17:04
Hot Stocks
ESPN+ to become exclusive distributor of UFC Pay-Per-View events »

UFC and ESPN+ announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Apr

STML

Stemline

$12.92

-0.71 (-5.21%)

17:02
03/18/19
03/18
17:02
03/18/19
17:02
Recommendations
Stemline analyst commentary at Piper Jaffray »

Stemline sees positive…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

REV

Revlon

$19.39

0.42 (2.21%)

17:02
03/18/19
03/18
17:02
03/18/19
17:02
Hot Stocks
Revlon down 15% after Q4 results miss estimates »

The company also…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Mar

ATR

AptarGroup

$103.69

0.75 (0.73%)

17:01
03/18/19
03/18
17:01
03/18/19
17:01
Hot Stocks
AptarGroup's Bidose approved by FDA for breakthrough treatment of depression »

Aptar Pharma announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

  • 01

    May

  • 01

    May

XELA

Exela Technologies

$3.82

-0.03 (-0.78%)

16:57
03/18/19
03/18
16:57
03/18/19
16:57
Earnings
Exela Technologies sees FY19 revenue $1.66B-$1.7B, consensus $1.68B »

Sees FY19 adjusted EBITDA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Mar

XELA

Exela Technologies

$3.82

-0.03 (-0.78%)

16:56
03/18/19
03/18
16:56
03/18/19
16:56
Earnings
Exela Technologies reports Q4 revenue $399.6M, consensus $401.4M »

Reports Q4 adjusted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Mar

BIO

Bio-Rad

$313.64

3.58 (1.15%)

16:55
03/18/19
03/18
16:55
03/18/19
16:55
Hot Stocks
Bio-Rad extends 10-K filing by 15 days to complete year-end procedures »

In a regulatory 8-K…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AERI

Aerie Pharmaceuticals

$47.09

0.09 (0.19%)

16:55
03/18/19
03/18
16:55
03/18/19
16:55
Conference/Events
Aerie Pharmaceuticals management to meet with JMP Securities »

Group Dinner Meeting to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Mar

  • 19

    Mar

  • 08

    Apr

NOMD

Nomad Foods

$21.45

-0.07 (-0.33%)

16:54
03/18/19
03/18
16:54
03/18/19
16:54
Syndicate
Nomad Foods files to sell 20M ordinary shares »

Goldman Sachs & Co.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FIS

FIS

$108.14

-0.73 (-0.67%)

, WP

Worldpay

$108.52

9.8 (9.93%)

16:54
03/18/19
03/18
16:54
03/18/19
16:54
Conference/Events
FIS management to meet with Wolfe Research »

Senior Payments & IT…

FIS

FIS

$108.14

-0.73 (-0.67%)

WP

Worldpay

$108.52

9.8 (9.93%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Mar

  • 18

    Mar

  • 26

    Mar

  • 27

    Mar

  • 28

    Mar

  • 04

    Apr

ORN

Orion Group

$4.23

0.145 (3.55%)

16:52
03/18/19
03/18
16:52
03/18/19
16:52
Hot Stocks
Orion Group delays filing of Form 10-K »

Orion Group Holdings said…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Mar

YEXT

Yext

$23.00

0.33 (1.46%)

16:50
03/18/19
03/18
16:50
03/18/19
16:50
Syndicate
Yext files to sell 6.1M shares of common stock »

Goldman Sachs & Co.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.